ArticleBlood advances2019

LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.

Neil Beeharry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.